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Abstract—Because posttraumatic stress disorder (PTSD) is 
both prevalent and underrecognized, routine primary care-based 
screening for PTSD has been implemented across the Veterans 
Health Administration. PTSD is frequently complicated by the 
presence of comorbid chronic pain, and patients with both con-
ditions have increased symptom severity and poorer prognosis. 
Our objective was to determine whether the presence of pain 
affects diagnosis and treatment of PTSD among Department of 
Veterans Affairs (VA) patients who have a positive PTSD 
screening test. This retrospective cohort study used clinical and 
administrative data from six Midwestern VA medical centers. 
We identified 4,244 VA primary care patients with a positive 
PTSD screen and compared outcomes for those with and with-
out a coexisting pain diagnosis. Outcomes were three clinically 
appropriate responses to positive PTSD screening: (1) mental 
health visit, (2) PTSD diagnosis, and (3) new selective serotonin 
reuptake inhibitor (SSRI) prescription. We found that patients 
with coexisting pain had a lower rate of mental health visits than 
those without pain (hazard ratio: 0.889, 95% confidence inter-
val: 0.821–0.962). There were no significant differences in the 
rate of PTSD diagnosis or new SSRI prescription between 
patients with and without coexisting pain.
Key words: comorbidity, health services research, healthcare 
utilization, mental health, pain, posttraumatic stress disorder, 
primary care, screening, Veterans, Veterans health.
INTRODUCTION
Posttraumatic stress disorder (PTSD) is both preva-
lent and underrecognized in primary care. Prior to opera-
tions in Iraq and Afghanistan, the point prevalence of 
PTSD among Department of Veterans Affairs (VA) pri-
mary care patients was estimated at 11.5 percent and the 
diagnosis was recognized by the primary care provider in 
less than 50 percent of cases [1]. Routine screening with 
the 4-item Primary Care PTSD Screen (PC-PTSD) has 
Abbreviations: CI = confidence interval, ICD-9 = Interna-
tional Classification of Diseases-9th Revision, PC-MHI = Pri-
mary Care-Mental Health Integration, PC-PTSD = Primary 
Care PTSD Screen, PTSD = posttraumatic stress disorder, 
SSRI = selective serotonin reuptake inhibitor, VA = Depart-
ment of Veterans Affairs.
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early recognition of PTSD [2].
PTSD is frequently complicated by the presence of 
comorbid chronic pain. Studies of Veterans in all eras 
since Vietnam have yielded high rates of comorbidity 
between the two conditions [3–5]. Patients with comor-
bid PTSD and pain have worse symptom severity, worse 
prognosis and treatment outcomes, greater levels of 
disability, worse quality of life, greater levels of psycho-
logical distress, and worse maladaptive thinking and cop-
ing patterns [6–12]. Theoretical models have postulated 
underlying vulnerabilities that predispose the develop-
ment of both chronic pain and PTSD [13] as well as mul-
tiple ways in which the two conditions exacerbate and 
maintain one another [14].
Previous research has shown that co-occurrence of 
depression and pain is associated with a decreased likeli-
hood that depression will be appropriately diagnosed and 
treated [15]. This may occur because patients or clini-
cians prefer to focus on managing physical symptoms 
[16]. Whether similar effects occur in comorbid PTSD 
and pain is unknown, but it is plausible given the com-
monalities between chronic pain and PTSD of avoidant 
coping style, reduced activity, and social withdrawal that 
may affect healthcare utilization [14]. Depression man-
agement has been the focus of considerable attention in 
primary care and is now principally managed by general-
ist providers in primary care. PTSD differs in that it has 
received less attention in primary care and the most 
effective evidence-based therapies for PTSD are typically 
delivered in mental health settings; however, initial diag-
nosis and treatment or referral usually occur in primary 
care. Following a positive screen and further evaluation 
of symptoms, current VA guidelines advise primary care 
providers to manage PTSD by initiating pharmacother-
apy (primarily selective serotonin reuptake inhibitors 
[SSRIs]) and/or referring to psychotherapy [17].
Our objective was to determine whether coexisting 
pain affects diagnosis and treatment of PTSD among VA 
patients who have a positive PTSD screening test in pri-
mary care. Based on previous literature on chronic pain 
and comorbid depression in primary care patients [16], we 
hypothesized that the presence of pain would predict lon-
ger delays in PTSD evaluation and treatment outcomes 
following positive PTSD screenings in primary care. We 
evaluated time to mental health visit, time to PTSD diag-
nosis, and time to new SSRI prescription as our outcomes.
METHODS
This retrospective cohort study included patients 
receiving care within Veterans Integrated Service Net-
work 11, the VA regional healthcare network serving 
Michigan, Indiana, and Illinois. Clinical and administra-
tive data were extracted from local databases of six VA 
medical centers. We included patients who had a positive 
PTSD screening test between January 1, 2001, and Janu-
ary 1, 2007, and had a primary care visit within 30 days 
after the positive screening. We excluded patients from 
this analysis if they had a preexisting PTSD diagnosis 
(International Classification of Diseases-9th Revision 
[ICD-9] 309.81) or if they had no primary care visit 
within 30 days of the positive screening test. Outcomes 
that occurred up to January 1, 2008, were analyzed.
Measures
VA clinical sites included in this study used the PC-
PTSD to screen for PTSD in primary care clinics. The 
PC-PTSD was developed and validated among Veterans 
seen in outpatient VA primary care clinics and imple-
mented nationally. A score of 3 has been determined to 
be the optimally efficient cutoff and is used by VA as the 
cutoff for a positive screen [2,18]; accordingly, we con-
sidered a score of 3 to be a positive screen for this study. 
A positive screen on the PC-PTSD has a positive predic-
tive value of 0.65 and a negative predictive value of 0.92 
for clinical PTSD diagnosis [2].
The primary independent variable was coexisting 
pain, defined as an ICD-9 diagnostic code for a pain 
diagnosis in the year prior to the positive PTSD screen. 
We used ICD-9 codes for headache (346, 307.81, 784.0, 
62.72, 339), back pain (720–724), arthritis and joint pain 
(710–719, 725–739.9), and nonspecific pain conditions 
(780.96, 307.8, 307.89, 338), which account for the vast 
majority of chronic pain diagnoses among Veterans [19–
22]. We also used ICD-9 codes to determine the presence 
of depression (296.2, 296.3, 311), alcohol use disorder 
(303.9, 305.0), and drug use disorder (304, 305.2–305.9) 
in the year prior to the positive PTSD screen.
Outcomes
We examined outcomes representing potential clinical 
responses to positive PTSD screening. The screening out-
comes examined were (1) time to mental health visit, 
(2) time to PTSD diagnosis, and (3) time to new SSRI pre-
scription. Mental health visits included those to both 
39
OUTCALT et al. PTSD screening outcomes with comorbid chronic paingeneral mental health and substance use disorder clinics. 
PTSD diagnosis was defined by an ICD-9 code of 309.81. 
SSRI use was evaluated by review of VA outpatient phar-
macy prescription dispensing data, which included medi-
cation names and dates for all prescriptions filled.
Statistical Analysis
We compared characteristics of patients with and 
without coexisting pain using chi-square and t-tests for 
categorical and continuous variables, respectively. Sur-
vival analyses of time from first positive PTSD screening 
to time of mental health visit, time of PTSD diagnosis, 
and time of new SSRI prescription were conducted using 
Kaplan-Meier estimates for determining median time to 
event and event rates at specific times. Analyses of time 
to SSRI prescriptions excluded participants with an SSRI 
prescription in the prior year. We then used Cox’s propor-
tional hazards regression to evaluate the association 
between coexisting pain and PTSD screening outcomes 
over time; separate Cox models were used to determine 
the effect of comorbid pain on each outcome. Cox propor-
tional hazards assume hazard ratios of effects are constant 
over time. Each model included the following covariates: 
age, sex, mental health visit in the previous year, depres-
sion, alcohol disorder, drug disorder, and medical comor-
bidity as derived from the Romano adaptation of the 
Charlson index [23–24]. Interactions between site and 
pain were not significant, so site-specific analyses were 
not conducted. Analyses were conducted using SAS 9.2 
(SAS Institute Inc; Cary, North Carolina).
RESULTS
After exclusion of 1,361 patients with a prior PTSD 
diagnosis and 479 who had no primary care visit within 
30 days of PTSD screening, the cohort included 4,244 
patients with a positive PTSD screen. The majority of 
included patients had a primary care visit the same day as 
their PTSD screening test (n = 4,028, 94.9%). The mean 
age was 50.4, and 91.9 percent of patients were male. 
Race data were missing on 56.1 percent of cohort mem-
bers. Half of the cohort (49.6%) had a coexisting pain 
diagnosis, and 38.6 percent had a current analgesic pre-
scription (Table 1). Patients with a pain diagnosis were 
slightly younger (48.8 vs 52.0 yr old, p < 0.001)
Characteristic Mean ± SD or n (%)






Depression Diagnosis 1,331 (31.4)
Alcohol Disorder Diagnosis 415 (9.8)
Drug Disorder Diagnosis 178 (4.2)
Mental Health Visit in Past Year 907 (21.4)
Comorbidity (Charlson Index score) 0.64 ± 1.01




Current Pain Medication 1,638 (38.6)
Pain Score† (4) 1,689 (39.8)
 and 
more often had depression (33.4% vs 29.4%, p = 0.005) 
than those without pain (Table 2).
Mental Health Visit
Overall, the median time to a mental health visit was 
5.7 mo (95% confidence interval [CI]: 4.6–6.9 mo) and 
56.4 percent had a mental health visit in the year after the 
positive PTSD screening result. Table 3 shows the num-
ber of patients with a mental health visit at 3, 6, 9, and 
12 mo after the positive PTSD screening test. Patients 
with coexisting pain had a statistically significant lower rate 
of mental health visits than those without pain (Table 4);
however, this difference was small. In the multivariate 
model, patients with pain had a lower rate of mental 
health visits (HR: 0.889, 95% CI: 0.821–0.962) than 
those without pain.
Posttraumatic Stress Disorder Diagnosis
During the study follow-up period, 1,280 (30%) 
patients who had a positive PTSD screen received a 
PTSD diagnosis. Table 3 shows the number of patients 
who received a PTSD diagnosis at 3, 6, 9, and 12 mo 
after the positive PTSD screening test. For those who 
received a PTSD diagnosis, the median time to diagnosis 
was 12.7 mo. Patients with and without coexisting pain 
did not significantly differ in PTSD diagnosis rates (HR: 
0.968, 95% CI: 0.866–1.082).
Table 1.
Baseline characteristics of patients who screened positive for 







*Some participants recorded 1 pain location.
†Self-rated between 0 and 10 by patients.
SD = standard deviation.
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Age (yr) 52.0 ± 15.9 48.8 ± 15.6 <0.001
Male 1,984 (92.7) 1,916 (91.1) 0.05
Depression Diagnosis 629 (29.4) 702 (33.4) 0.005
Alcohol Disorder Diagnosis 204 (9.5) 211 (10.0) 0.59
Drug Disorder Diagnosis 83 (3.9) 95 (4.5) 0.30
Mental Health Visit in Past Year 443 (20.7) 464 (22.1) 0.28
Charlson Comorbidity Index Score† <0.001
1,205 (56.3) 1,361 (64.7)
574 (26.8) 452 (21.5)
361 (16.9) 291 (13.8)
Time Point (mo) Mental Health Visit* PTSD Diagnosis New SSRI Prescription
3 1,842 (44.7) 929 (22.3) 667 (0.2)
6 2,063 (50.3) 1,017 (24.5) 784 (0.2)
9 2,194 (53.8) 1,074 (26.1) 875 (0.3)
12 2,283 (56.4) 1,132 (27.7) 938 (0.3)
Outcome Pain vs No Pain, HR (95% CI) p-Value
Mental Health Visit 0.889 (0.821–0.962) 0.004
PTSD Diagnosis 0.968 (0.866–1.082) 0.57
New SSRI Prescription 0.996 (0.885–1.122) 0.95
We subsequently examined the relationship between 
mental health visits and PTSD diagnosis. Patients who 
had a mental health visit after their positive PTSD screen 
were more likely than those without a mental health visit 
to receive a diagnosis of PTSD (HR: 1.388, 95% CI: 
1.232–1.563). Among those who received a PTSD diag-
nosis, 780 (59.4%) were diagnosed by a mental health 
clinician.
Selective Serotonin Reuptake Inhibitor Prescription
Approximately 17 percent of participants (n = 720) 
had received an SSRI prescription within 12 mo preced-
ing their PTSD screening and were thus excluded from 
the SSRI survival analysis. Table 3 demonstrates the 
number of patients with a new SSRI prescription at 3, 6, 
9, and 12 mo following the positive PTSD screen. There 
was no significant difference in time to SSRI prescription 
between the positive and negative PTSD screening 
groups (Table 4).
DISCUSSION
Contrary to our hypotheses, coexisting pain did not 
substantially affect follow-up of positive PTSD screen-
ing. Comorbid pain was not associated with significant 
Table 2.
Unadjusted comparison of patients who screened positive for posttraumatic stress disorder with and without pain. Data presented as mean ± 




*Unadjusted comparison between those with and without pain.
†Categorized for ease of interpretation. Range = 0–8. p-Value is for continuous score.
Table 3.
Outcomes of screening at 3, 6, 9, and 12 mo after positive posttraumatic stress disorder (PTSD) screen, n (%).
*Kaplan-Meier survival rates.
SSRI = selective serotonin reuptake inhibitor.
Table 4.
Relationship between pain comorbidity and outcomes of screening.
Note: Survival analysis adjusted for age, sex, prior mental health visit, depression, alcohol disorder, drug disorder, and Charlson comorbidity index score.
CI = confidence interval, HR = hazard ratio, PTSD = posttraumatic stress disorder, SSRI = selective serotonin reuptake inhibitor.
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prescription. Although patients with pain demonstrated 
longer times between a positive PTSD screen and a men-
tal health visit, the difference was small.
Nearly half of the sample did not visit a mental 
health provider following the positive PTSD screening in 
primary care, 70 percent were not diagnosed with PTSD 
during the follow-up period, and 83 percent did not 
receive SSRI medication. Our results are consistent with 
data from previous research but show even lower rates of 
postscreening diagnosis and pharmacotherapy. A recent 
study of primary care screening outcomes demonstrated 
that only about half of patients with positive PTSD 
screens (56%) progressed to some form of treatment 
(either medication only, psychotherapy only, or a combi-
nation of the two) [25]. In a similar study, only 39 percent 
of patients attended a mental health visit and 48 percent 
received antidepressant medication following a positive 
PTSD screening test [26].
We do not know the optimal rates of these follow-up 
outcomes; presumably, some proportion of positive 
screening tests was determined by the primary care pro-
vider to represent false positives that did not require 
follow-up assessment or treatment outside primary care. In 
other cases, patient preference or barriers to mental health 
care may have affected outcomes. Prior literature indicates 
that many patients do not acknowledge their PTSD, are not 
aware that it can be treated, do not want treatment for it, 
or perceive a stigma related to seeking and receiving 
treatment [27–29].
A large majority of the sample was not diagnosed 
with PTSD following a positive screen in primary care; 
however, we do not know how many patients were evalu-
ated and found not to meet diagnostic criteria for PTSD 
or how many patients were not evaluated at all. Previous 
literature examining PTSD in primary care found that 
providers identified and documented PTSD in only 
11 percent of primary care patients with the diagnosis 
following positive PTSD screening [30]. In a separate 
study, primary care providers were more likely to label 
any evident distress as depression rather than the PTSD 
identified by research assessment instruments [31].
Although prior studies have found that comorbid 
pain is associated with a decreased likelihood that 
depression will be appropriately diagnosed and treated 
[13], we did not find a similar overall effect of comorbid 
pain on PTSD screening outcomes. This may be due to 
differences in the usual process of care for depression, 
which is most often managed in primary care, versus 
PTSD, which is usually managed in mental health clinics. 
Perhaps PTSD remains difficult to recognize and address 
in primary care regardless of comorbid medical condi-
tions despite the guidance of PTSD screening tools.
The last year of this study overlapped with the 2007 
start of the national implementation of the VA Primary 
Care-Mental Health Integration (PC-MHI) program [32]. 
This initiative systematically installed colocated and col-
laborative mental health providers within primary care 
clinics across VA. This program’s effect on outcomes of 
positive PTSD screening in primary care is not yet fully 
known. One study demonstrated the benefit of PC-MHI 
with improved consult completion rates and higher PTSD 
diagnosis rates as compared with referrals from specialty 
care [33]; however, there were no differences by referral 
source in follow-up visits in the PTSD clinic. The current 
study is limited by the age of the data and therefore does 
not account for the ongoing efforts across VA to improve 
PTSD care; we cannot infer whether PTSD screening 
outcomes have changed since the data were collected. 
Future research should compare postscreening PTSD 
evaluation and treatment rates from before versus after 
the implementation of mental health programs in primary 
care to see what differences may emerge.
This study has additional limitations. First, as men-
tioned previously, we do not know the true rate of PTSD 
in the population and therefore are unable to evaluate 
appropriateness of follow-up among patients with and 
without pain. Second, diagnostic codes for pain are 
imprecise and noninformative regarding pain severity, 
pain control, and other pain outcomes, which is an inher-
ent limitation of administrative data sets. Third, these 
administrative data did not provide the reasons for which 
SSRIs were prescribed; it is plausible that some patients 
were started on an SSRI for depression rather than PTSD. 
It also may be the case that mental health visits were ini-
tiated for reasons other than PTSD. Finally, although this 
study included diverse Midwestern VA sites, findings 
may not generalize to other VA and non-VA settings.
Despite its limitations, this study makes an important 
contribution to the literature as the first to examine the 
effect of comorbid pain on the diagnosis and treatment of 
PTSD following a positive PTSD screening test in VA 
primary care. A recent systematic review and report on 
PTSD screening in primary care indicated a need for 
studies “examining the impact of mental health screening 
on the primary care encounter within the VA system” [34, 
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the likely multifaceted explanations behind these find-
ings. For example, it would be important to understand 
whether age or era of service affects PTSD screening out-
comes; newly returning Operation Iraqi Freedom/Opera-
tion Enduring Freedom/Operation New Dawn Veterans 
are typically younger than our sample’s average age of 
50.4 yr and have often been exposed to more combat 
experiences that are traumatic and injurious and thus may 
demonstrate different patterns of healthcare utilization 
related to symptoms of PTSD and chronic pain [35].
CONCLUSIONS
We examined outcomes of positive PTSD screening 
in VA primary care among Veterans with and without 
pain diagnoses. Patients with coexisting pain did not dif-
fer in time by PTSD diagnosis or new SSRI prescription 
and had longer delays to mental health visits than those 
without pain. Given that there are effective psychological 
treatments for chronic pain (i.e., cognitive behavioral 
therapy [36], acceptance and commitment therapy [37]) 
and PTSD (i.e., prolonged exposure [38], cognitive pro-
cessing therapy [39]), it is crucial to ensure that Veterans 
living with both conditions are offered these interven-
tions. Across the board, regardless of pain comorbidity, 
diagnosis and treatment rates following positive PTSD 
screenings were low. This gap following positive PTSD 
screens in primary care represents an area of potential 
promise for implementation strategies to identify and 
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